[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582952":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":25,"responsibleParty":91,"collaborators":10,"id":93,"slug":94,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":97,"acronym":10,"eligibilityCriteria":98,"healthyVolunteers":95,"sex":99,"minAge":10,"maxAge":100,"enrollmentInfo":101,"targetDuration":10,"studyType":104,"phases":10,"briefSummary":105,"conditions":106,"keywords":111,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"Meyer Children's Hospital IRCCS","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Monotherapy",null,"Patients taking only one drug acting on QT interval",{"label":13,"type":10,"description":14,"interventionNames":10},"Monotherapy to monotherapy","Patients who have switched from a drug acting on QT interval to another",{"label":16,"type":10,"description":17,"interventionNames":10},"Polytherapy","Patients taking more than one drug acting on QT interval",[19],{"name":20,"role":21,"phone":22,"phoneExt":23,"email":24},"Tiziana Pisano, MD","CONTACT","3498705830","+39","tiziana.pisano@meyer.it",[26,40,53,63,73,82],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"Neuropsichiatria Infantile, IRCCS - OC Associazione Oasi Maria SS. ONLUS","NOT_YET_RECRUITING","Troina","Enna","94018","Italy","IT",{"type":35,"coordinates":36},"Point",[37,38],14.59605,37.78437,{"lat":38,"lon":37},{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":32,"countryCode":33,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"AOU Meyer IRCCS","RECRUITING","Florence","FI","50139",{"type":35,"coordinates":47},[48,49],11.24626,43.77925,{"lat":49,"lon":48},[52],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":24},{"facility":54,"status":42,"city":55,"state":56,"zip":57,"country":32,"countryCode":33,"cosmosGeoPoint":58,"geoPoint":62,"contacts":10},"IRCCS Fondazione Stella Maris","Calambrone","Pisa","56128",{"type":35,"coordinates":59},[60,61],10.3,43.58333,{"lat":61,"lon":60},{"facility":64,"status":65,"city":66,"state":10,"zip":67,"country":32,"countryCode":33,"cosmosGeoPoint":68,"geoPoint":72,"contacts":10},"Neuropsichiatria infantile, Policlinico S.Orsola-Malpighi","ACTIVE_NOT_RECRUITING","Bologna","40138",{"type":35,"coordinates":69},[70,71],11.33875,44.49381,{"lat":71,"lon":70},{"facility":74,"status":28,"city":75,"state":10,"zip":76,"country":32,"countryCode":33,"cosmosGeoPoint":77,"geoPoint":81,"contacts":10},"Clinica di Neuropsichiatria dell'Infanzia e dell'adolescenza, Ospedale Pediatrico A. Cao ARNAS G. Brotzu","Cagliari","09121",{"type":35,"coordinates":78},[79,80],9.11917,39.23054,{"lat":80,"lon":79},{"facility":83,"status":28,"city":84,"state":10,"zip":85,"country":32,"countryCode":33,"cosmosGeoPoint":86,"geoPoint":90,"contacts":10},"Neuropsichiatria Infantile, Azienda Ospedaliera-Universitaria \"Gaetano Martino\"","Messina","98124",{"type":35,"coordinates":87},[88,89],15.55256,38.19394,{"lat":89,"lon":88},{"type":92,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100582952","psychotropic-drug-induced-qt-prolongation-and-ecg-monitoring-in-the-pediatric-population-100582952",false,"NCT06870006","Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population","Inclusion Criteria:\n\n* Admitted to psychiatry ward\n* Starting a psychotropic drug acting on QT interval\n\nExclusion Criteria:\n\n* Age \\>18aa\n* History of administration of drug acting on QT interval in the 3 months prior","ALL","18 Years",{"count":102,"type":103},100,"ESTIMATED","OBSERVATIONAL","Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psychotropic drugs are associated with an increased risk of QT prolongation, which is why in clinical practice a baseline ECG is performed before a psychotropic drug is prescribed. However, there are no validated protocols establishing when to repeat this examination or describing clinical events when this examination should be repeated in clinical follow-up.\n\nThe study aims to investigate the incidence of QTc prolongation events as a side effect of chronic psychotropic drug administration. For this purpose, ECGs will be recorded and confounding factors of patients at the beginning of psychotropic therapy and after 3, 6 and 12 months will be analyzed.",[107,108,109,110],"Eating Disorders","Mood Disorders in Children and Adolescents","Psychotic Disorder","QTc Intervals Changes",[112,113],"QTc interval","psychotropic drugs","2026-03-17",{"date":116,"type":117},"2026-03-18","ACTUAL",{"date":119,"type":117},"2024-01-01",{"date":121,"type":103},"2027-01",{"name":5,"class":6},6]